These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6144219

  • 1. [Clinical efficacy of leponex according to the findings of an international study].
    Panteleeva GN, Tsutsul'kovskaia MIa, Beliaev BS, Cheshkova E, Pavlovskiĭ P.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):393-401. PubMed ID: 6144219
    [Abstract] [Full Text] [Related]

  • 2. [Long-term treatment of schizophrenic patients with leponex (clozapine)].
    Panteleeva GP, Tsutsul'kovskaia MIa, Mazurskiĭ MB, Danilenko IuM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1247-56. PubMed ID: 696118
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
    Gamburg AL, Aranovich AG, Kotel'kevich IuN, Omorokov BM, Rasniuk VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1211-6. PubMed ID: 6111169
    [Abstract] [Full Text] [Related]

  • 4. Clozapine in the treatment of schizophrenic patients: an international multicenter trial.
    Panteleeva GP, Kovskaya MY, Belyaev BS, Minsker EI, Vynar O, Ceskova E, Svetska J, Libiger J, Korinkova V, Novotny V.
    Clin Ther; 1987; 10(1):57-68. PubMed ID: 3329966
    [Abstract] [Full Text] [Related]

  • 5. [Psychotropic drug therapy using maintenance dosage pumps].
    Smulevich AB, Vorob'ev VIu, Tarasova TP, Abrosimov AI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(6):888-93. PubMed ID: 2888248
    [Abstract] [Full Text] [Related]

  • 6. [Problem of side effects of leponex on blood (multicenter inter- national study)].
    Panteleeva GP, Gamkrelidze ShA, Dikaia VI, Magalif AA, Okuneva TP, Perevozniuk AG, Shtemberg K, Filip V, German E, Zapletanek M.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):70-3. PubMed ID: 1665659
    [Abstract] [Full Text] [Related]

  • 7. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
    Bret P, Jolivel C, Bret MC, Veylit S, Martin C, Garcia P.
    Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
    [Abstract] [Full Text] [Related]

  • 8. Clozapine maintenance therapy in schizophrenia.
    Gaszner P, Makkos Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [Abstract] [Full Text] [Related]

  • 9. [Clinico-pharmacokinetic prediction of the efficacy of treatment: the test dose].
    Beliaev BS, Sirota LA, Minsker EI, Panteleeva GP, Tsutsul'kovskaia MIa.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 May; 84(3):401-6. PubMed ID: 6720182
    [Abstract] [Full Text] [Related]

  • 10. [Long-term clinical experience with clozapine].
    Gelly F, Chambon O, Marie-Cardine M.
    Encephale; 1997 May; 23(5):385-96. PubMed ID: 9453932
    [Abstract] [Full Text] [Related]

  • 11. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM, Hallak JE, Haddad P, Leahy A, Byrne A, Strickland PL, Anderson IM, Zuardi AW, Deakin JF.
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE, Chong SA, Ngui F, Winslow M, Devan GS, Leong OK, Choo CH.
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

  • 16. [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics].
    Vasil'ev AA, Nuller IuL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Jan; 86(8):1217-22. PubMed ID: 2877531
    [Abstract] [Full Text] [Related]

  • 17. [Clozapine for resistant schizophrenia and characteristics of those responding].
    Talmon Y, Guy N, Wittenberg N.
    Harefuah; 1995 Dec 01; 129(11):451-4, 536. PubMed ID: 8846949
    [Abstract] [Full Text] [Related]

  • 18. [Clinical effects of clozapine: effect on negative symptoms].
    Llorca PM, Lançon C, Auquier P, Bougerol T.
    Encephale; 1996 Dec 01; 22(4):287-92. PubMed ID: 9035984
    [Abstract] [Full Text] [Related]

  • 19. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.
    Exp Clin Psychopharmacol; 2007 Dec 01; 15(6):563-8. PubMed ID: 18179309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.